RevMedx’s XSTAT™ dressing was recognized with a MEDY award for the most disruptive technology at FutureMed November 2013 (Hotel Del Coronado, San Diego, California.) FutureMed is a specialized executive program by Singularity University, focused on the impact of rapidly advancing technologies on the transformation of health, and biomedicine.

Fayetteville, North Carolina and Stafford, Virginia (August 30, 2013) – Panakeia, LLC, which distributes healthcare solutions to the Military Health System, announced today it has entered into a distribution agreement with RevMedx, Inc. to promote and distribute AirWrap™.

Oregon Health and Science University (OHSU) and RevMedx Inc. won a USAID/Gates-sponsored seed grant to develop a novel treatment for postpartum hemorrhage based on RevMedx’s XSTAT™ technology. The OHSU/RevMedx proposal was selected from more than 400 submissions in the Saving Lives at Birth Grand Challenge—an international effort to dramatically reduce maternal and neonatal deaths.